Auris Medical Holding Stock Debt To Equity
Auris Medical Holding fundamentals help investors to digest information that contributes to Auris Medical's financial success or failures. It also enables traders to predict the movement of Auris Stock. The fundamental analysis module provides a way to measure Auris Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Auris Medical stock.
Auris |
Auris Medical Holding Company Debt To Equity Analysis
Auris Medical's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Auris Medical Debt To Equity | 0.03 % |
Most of Auris Medical's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Auris Medical Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
CompetitionAccording to the company disclosure, Auris Medical Holding has a Debt To Equity of 0.031%. This is 99.94% lower than that of the Healthcare sector and 99.84% lower than that of the Biotechnology industry. The debt to equity for all United States stocks is 99.94% higher than that of the company.
Auris Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Auris Medical's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Auris Medical could also be used in its relative valuation, which is a method of valuing Auris Medical by comparing valuation metrics of similar companies.Auris Medical is currently under evaluation in debt to equity category among its peers.
Auris Fundamentals
Return On Equity | -71.91 | |||
Return On Asset | -21.99 | |||
Current Valuation | 32.76 M | |||
Shares Outstanding | 12.87 M | |||
Shares Owned By Insiders | 5.45 % | |||
Shares Owned By Institutions | 5.34 % | |||
Number Of Shares Shorted | 362.97 K | |||
Price To Earning | (1.05) X | |||
Price To Book | 2.07 X | |||
Price To Sales | 224.60 X | |||
Revenue | 174.47 K | |||
Gross Profit | 174.47 K | |||
EBITDA | (5.26 M) | |||
Net Income | (8.2 M) | |||
Cash And Equivalents | 11.26 M | |||
Cash Per Share | 0.88 X | |||
Total Debt | 523.92 K | |||
Debt To Equity | 0.03 % | |||
Current Ratio | 3.83 X | |||
Book Value Per Share | 1.47 X | |||
Cash Flow From Operations | (4.84 M) | |||
Short Ratio | 0.15 X | |||
Earnings Per Share | (1.49) X | |||
Beta | 1.37 | |||
Market Capitalization | 39.19 M | |||
Total Asset | 41 M | |||
Retained Earnings | (164.84 M) | |||
Working Capital | 31 M | |||
Current Asset | 39 M | |||
Current Liabilities | 8 M | |||
Z Score | 38.8 |
Thematic Opportunities
Explore Investment Opportunities
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Auris Stock
If you are still planning to invest in Auris Medical Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Auris Medical's history and understand the potential risks before investing.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |